AstraZeneca Secures $486 Million From U.S. Government for Coronavirus Antibody Cocktail

AstraZeneca (NYSE:AZN) has secured $486 million from the U.S. government's Biomedical Advanced Research and Development Authority to support the development of AZD7442, an antibody cocktail for the treatment and prevention of COVID-19.